SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-22-000131
Filing Date
2022-11-14
Accepted
2022-11-14 16:12:44
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opnt-20220930.htm   iXBRL 10-Q 1207514
2 EX-31.1 exhibit31109302022.htm EX-31.1 11537
3 EX-31.2 exhibit31209302022.htm EX-31.2 11379
4 EX-32.1 exhibit32109302022.htm EX-32.1 5622
5 EX-32.2 exhibit32209302022.htm EX-32.2 5546
  Complete submission text file 0001385508-22-000131.txt   5883382

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20220930.xsd EX-101.SCH 46047
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20220930_cal.xml EX-101.CAL 51430
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20220930_def.xml EX-101.DEF 270902
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20220930_lab.xml EX-101.LAB 513556
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20220930_pre.xml EX-101.PRE 430345
68 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20220930_htm.xml XML 831777
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 221385406
SIC: 2834 Pharmaceutical Preparations